Radiographic Response of Brain Metastases in Patients With Non-small Cell Lung Cancer Receiving Bevacizumab

被引：0
|
作者：
Rhodes, S. B. [1 ]
Ewend, M. G. [1 ]
Morris, D. E. [1 ]
Chu, H. [1 ]
Socinski, M. A. [1 ]
机构：
[1] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S537 / S537
页数：1
相关论文
共 50 条
  • [21] FACTORS PREDICTING BRAIN METASTASES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Hsiao, S.
    Chung, C.
    Liu, H. E.
    ANNALS OF ONCOLOGY, 2012, 23 : 428 - 429
  • [22] Platelet indices in non-small cell lung cancer patients with brain metastases
    Li, Ming-Ming
    Wang, Xin
    Yun, Zhi-Yuan
    Wang, Rui-Tao
    Yu, Kai-Jiang
    CANCER BIOMARKERS, 2019, 24 (04) : 515 - 519
  • [23] Multimodality management of non-small cell lung cancer patients with brain metastases
    Ricciardi, Serena
    de Marinis, Filippo
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (02) : 86 - 93
  • [24] The risk factors for brain metastases in patients with non-small cell lung cancer
    Lim, Jun Hyeok
    Um, Sang-Won
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [25] Treatment options for brain metastases in patients with non-small cell lung cancer
    Sadaf Taimur
    Martin J. Edelman
    Current Treatment Options in Oncology, 2003, 4 (1) : 89 - 95
  • [26] SURVIVAL OF PATIENTS WITH BRAIN METASTASES AND NON-SMALL CELL LUNG CANCER (NSCLC)
    Randhawa, J. K.
    Patel, S. P.
    Stokes, T. C.
    THORAX, 2009, 64 : A148 - A148
  • [27] Response of Brain Metastases in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy and Brain Directed Radiotherapy
    Sanoyan, D. Akhoundova
    Hullner, M.
    Kraft, J.
    Bankel, L.
    Lee, S.
    Ansratschke, N.
    Fontecedro, A. Curioni
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S930 - S930
  • [28] The management of brain metastases in non-small cell lung cancer
    Owen, Scott
    Souhami, Luis
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [29] Radiogenomics for the prognosis in advanced non-small cell lung cancer patients receiving bevacizumab.
    Li, Butuo
    Jiang, Chao
    Pang, Linlin
    Fan, Bingjie
    Ding, Mingjun
    Sun, Xindong
    Yu, Jinming
    Wang, Linlin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Outcome of combined bevacizumab and irinotecan for patients with progressive brain metastases from non-small cell lung cancer (NSCLC).
    Brosnan, Evelyn M.
    Fadul, Camilo E.
    Dragnev, Konstantin H.
    Davis, Melissa C.
    Shah, Khushboo A.
    Eskey, Clifford J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345